Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ABUS
ABUS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ABUS ETF News Today | Earnings, Events & Price Alerts
ABUS News
Midday Market Moves: Notable Stock Fluctuations
14m ago
CNBC
Moderna Settles Patent Dispute with Arbutus and Genevant
4h ago
seekingalpha
STAAR Surgical Reports Disappointing Q4 Results, Shares Plummet
5h ago
Benzinga
Moderna Settles for $950 Million with Arbutus, Eyes Future Growth
5h ago
Benzinga
Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and Others
8h ago
Barron's
Moderna Reaches Settlement in Lawsuit: Implications for Its Stock.
8h ago
Barron's
Moderna Shares Surge as Major Risk is Removed.
8h ago
Barron's
Box Inc Q4 Earnings Exceed Expectations
9h ago
Benzinga
Moderna Settles for Up to $2.25 Billion with Arbutus and Genevant
20h ago
stocktwits
Moderna Settles $2.25 Billion Patent Dispute with Genevant and Arbutus
21h ago
Newsfilter
Delaware Judge Dismisses Key Defenses in Moderna Patent Case
Feb 18 2026
seekingalpha
Arbutus Biopharma Shares Rise 10% After Patent Ruling
Feb 02 2026
seekingalpha
Health Care Stocks Decline as NYSE Health Care Index Eases 0.5%
Jan 16 2026
Yahoo Finance
Arbutus Biopharma (ABUS) Patent Revocation Leads to 18% Stock Crash
Jan 16 2026
stocktwits
Arbutus Biopharma (ABUS) Patent Revocation Leads to 14% Pre-Market Drop
Jan 16 2026
seekingalpha
Chardan Capital Reaffirms Buy Rating for Arbutus Biopharma with $5 Price Target Intact
Nov 14 2025
Benzinga
Show More News
